Small molecule inhibitor screen identifies synergistic activity of the bromodomain inhibitor CPI203 and bortezomib in drug resistant myeloma is a research paper published in Oncotarget (2015). On theSindex it has a DataRank of 2.1. It has been cited 43 times, with 41 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.568
From this paper's citation signal
Citation Network Contribution
1.5
From 39 citing papers with measurable signal
NCI NIH HHS
Grant: R00 CA151457
NCI NIH HHS
Grant: R01 CA183974
NCI NIH HHS
Grant: 1R01CA183974
NCI NIH HHS
Grant: 5R00CA151457
Howard Hughes Medical Institute
FWCI
3.58
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals